Hypertrophic cardiomyopathy sometimes first presents as sudden death in apparently healthy young people, especially during sport. Over recent years, people (mean age 42) with an antemortem diagnosis of HCM have increasingly been fitted with implantable cardioverter-defibrillators, […]
Thanks to this little piece in this week’s New England Journal, Oscar is currently the world’s most famous cat, for his unerring ability to sense the impending death of residents in the nursing home where he was reared as a stray kitten. […]
At home we’re watching old episodes of Cardiac Arrest, a series written 13 years ago by an ex-junior-doctor which depicts hospital medicine through a fog of anger and sleep deprivation. The only dignity seen in the series is in the behaviour of ethnic-minority relatives of patients killed by the system. […]
Cannabis is very widely used, particularly by people who later show signs of psychosis; […]
Various groups of higher beings keep watch over the lives of us humble mortals, including the American Council on Science and Public Health, which here pronounces on reducing sodium intake to prevent cardiovascular disease. […]
All over England, buddleias have been in flower for weeks already, often sprawling over railway embankments and waste ground, or lodged in the mortar of high walls and chimneys to the greater peril of the populace. […]
This trial prejudged its outcome by calling itself the Women’s Healthy Eating and Living (WHEL) study; it was based on the supposition that a diet very high in vegetables, fruit, and fibre and low in fat might reduce cancer-related events and mortality in women with breast cancer. […]
A big international trial gives a nice clear answer to an important clinical question: might patients with peripheral vascular disease do better taking warfarin as well as an antiplatelet agent? […]
This study of self-monitoring in type 2 diabetes calls into question a widely-used and expensive intervention and has drawn a stream of responses ever since it was first posted on the BMJ website some weeks ago. […]
A useful short reminder piece about new treatments for age-related macular degeneration. The story is much as was told in the New England Journal last October, under the apt heading “The Price of Sight”: […]